Last reviewed · How we verify
KF-0210 tablets, 120 mg
At a glance
| Generic name | KF-0210 tablets, 120 mg |
|---|---|
| Also known as | KF-0210-0 |
| Sponsor | Keythera Pharmaceuticals (Australia) Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KF-0210 tablets, 120 mg CI brief — competitive landscape report
- KF-0210 tablets, 120 mg updates RSS · CI watch RSS
- Keythera Pharmaceuticals (Australia) Pty Ltd portfolio CI